Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Closing in on All-Time Low

<< Previous

Bullboard Posts

Next >>

Post by mikeq113on Aug 22, 2023 1:18pm

141 Views

Post# 35600162

Closing in on All-Time Low

Truly impressive to see us revisiting share prices not seen in a decade. All because management is entirely bereft of any semblance of a capital markets communication strategy and continues to miss their own deadlines and estimates.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program